REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Intech Biopharm Ltd. (益得生物科技股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Intech Biopharm Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Intech Biopharm is a pharmaceutical company that specializes in developing Air Handling Units with BIBO Design for their HVAC system to minimize the impact of drug substances on employees and the environment.

Headquarters
3F., No.36, Ln. 358, Ruiguang Rd Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Intech Biopharm Ltd. (益得生物科技股份有限公司) report to view the information.

Website: http://www.intechbiopharm.com

Basic Information
Total Employees:
Purchase the Intech Biopharm Ltd. (益得生物科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Intech Biopharm Ltd. (益得生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Intech Biopharm Ltd. (益得生物科技股份有限公司) report to view the information.
Incorporation Date:
October 28, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
38.97%
Purchase this report to view the information.
5.35%
Purchase this report to view the information.
4.44%
Purchase this report to view the information.
0.87%
Purchase this report to view the information.
0.62%
Subsidiaries
Time Deposits with Original Maturity Over
0.54%
Company Performance
Financial values in the chart are available after Intech Biopharm Ltd. (益得生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
258.74%▲
Total operating revenue
193.69%▲
Operating Profit/Loss (EBIT)
2.98%▲
EBITDA
5.8%▲
Net Profit/Loss for the Period
-0.81%▼
Total Assets
1.14%▲
Total Equity
8.71%▲
Operating Profit Margin (ROS)
617.78%▲
Net Profit Margin
661.78%▲
Return on Equity (ROE)
2.11%▲
Debt/Equity
-12.42%▼
Quick Ratio
-0.18%▼
Cash Ratio
-0.05%▼

Similar companies

Bora Pharmaceuticals Co., Ltd.
 
Lotus Pharmaceutical Co., Ltd.
Great Tree Pharmacy Co.,Ltd.
 
PharmaEssentia Corp.
Cenra Inc.
 
China Chemical & Pharmaceutical Co., Ltd
Glory Biotech Co., Ltd.
 
Acer Medical Inc.
U-Neuron Biomedical Inc.
 
Enimmune Corporation
Lumosa Therapeutics Co., Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo